Connect with us

BIOTECH

Cannabis Science Inc (OTCMKTS:CBIS) Takes A Dive

Published

on

In the last trading session, the stock price of Cannabis Science Inc (OTCMKTS:CBIS) plunged more than 8% to close the day at $0.10. The decline came at a share volume of 39.82 million compared to average share volume of 23.97 million.

The buzz

Cannabis Science introduced its Global Consortium last year. This Consortium offers a framework to cooperate and associate with stakeholders globally. It links universities, corporations, individuals and foundations to share ideas, research and other relevant data, as well as to execute a cutting-edge research plan to advance delivery mechanisms and medicines from bench-to-bedside.

Last year, Cannabis Science enrolled to apply for U.S. Federal Government grants and contracts. As part of this enrollment process, the firm obtained its Federal CAGE Code, which is released by the Department of Defense’s Defense Logistics Agency CAGE Code Program Office. The company is one of the only firms in its market with the ability to get U.S. Federal Government grants and contracts.

Cannabis Science will use its relationships and expertise with University Medical Research Groups and Government Agencies to advance Cannabinoid Pharmaceutical Development, as well as to reconfigure availability to treatment with cannabinoids by building and designing efficient and effective medical clinics and pharmacies staffed by skilled health professionals.

Cannabis Science is set to a remarkable start in 2018 and the firm anticipates to report new pharmacy deals in the first quarter as it extends its presence from Coast to Coast and subsequently work their course from North to South.

With 29 states having approved some kind of Medical Marijuana, and as many as 7 more states anticipated to approve Medical Marijuana regulations this year, Cannabis Science is advancing to meet the demand and next will be assuring the rest of States to participate in this movement depending on the medical demands and needs of the patients.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement